Binge Eating Liraglutide Intervention

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study is a 17-week, single-center, double-blind, parallel-group, randomized placebo controlled trial that will test the efficacy of liraglutide 3.0 mg/d as compared to placebo in reducing the number of binge episodes per week, achieving remission from binge episodes, and in changes in body weight, global BED symptom improvement, cognitive restraint of food intake, dietary disinhibition, perceived hunger, quality of life, and depressed mood at treatment end.
Epistemonikos ID: 70a7835ae40899c881d33a43caf690dd5831f078
First added on: May 21, 2024